South Africa at the forefront of HIV prevention innovation
The introduction of Lenacapavir for HIV prevention in South Africa represents the culmination of more than a decade of strategic leadership and health system strengthening led by the National Department of Health. South Africa has been one of the few countries globally to make antiretroviral-based pre-exposure prophylaxis (PrEP) available as part of the Essential Medicines List and integrated within the country’s public primary healthcare (PHC) system.


